Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines

Author： Ellis C.A.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.78, Iss.1, 2003-03, pp. : 59-67

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

By Andreopoulou Eleni   Vigoda Ivette   Valero Vicente   Hershman Dawn   Raptis George   Vahdat Linda   Han Hyo   Wright John   Pellegrino Christine   Cristofanilli Massimo   Alvarez Ricardo   Fehn Karen   Fineberg Susan   Sparano Joseph  

Breast Cancer Research and Treatment, Vol. 141, Iss. 3, 2013-10 ,pp. : 429-435

Springer Publishing Company

Access to resources Recommend Favorite

Cimicifuga racemosa Extract Inhibits Proliferation of Estrogen Receptor-positive and Negative Human Breast Carcinoma Cell Lines by Induction of Apoptosis

By Hostanska K.  

Breast Cancer Research and Treatment, Vol. 84, Iss. 2, 2004-03 ,pp. : 151-160

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant tamoxifen-induced mammographic breast density reduction as a predictor for recurrence in estrogen receptor-positive premenopausal breast cancer patients

By Ko Kyung   Shin In   You Ji   Jung So-Youn   Ro Jungsil   Lee Eun  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 559-567

Springer Publishing Company

Access to resources Recommend Favorite

Lumpectomy and tamoxifen alone without additional radiotherapy for women 70 years of age or older with estrogen receptor-positive breast cancer

By Ferretti Gianluigi  

Breast Cancer Research and Treatment, Vol. 90, Iss. 3, 2005-04 ,pp. : 319-319

Springer Publishing Company

Access to resources Recommend Favorite

A relative ordering-based predictor for tamoxifen-treated estrogen receptor-positive breast cancer patients: multi-laboratory cohort validation

By Zhou Xianxiao   Li Bailiang   Zhang Yuannv   Gu Yunyan   Chen Beibei   Shi Tongwei   Ao Lu   Li Pengfei   Li Shan   Liu Chunyang   Guo Zheng  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 505-514

Springer Publishing Company

Access to resources Recommend Favorite